相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
Manoj Kumar Kashyap et al.
MOLECULAR CANCER (2018)
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
Yasamin Davatgaran-Taghipour et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Polyphenols delivery by polymeric materials: challenges in cancer treatment
Orazio Vittorio et al.
DRUG DELIVERY (2017)
Evaluation of ethyl gallate for its antioxidant and anticancer properties against chemical-induced tongue carcinogenesis in mice
Shalini Mohan et al.
BIOCHEMICAL JOURNAL (2017)
Anticancer Efficacy of Polyphenols and Their Combinations
Aleksandra Niedzwiecki et al.
NUTRIENTS (2016)
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
Giuliana Cavalloni et al.
ONCOTARGET (2016)
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
Ritesh Kotecha et al.
ONCOTARGET (2016)
Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis
Hai-Xia Qu et al.
JOURNAL OF THORACIC DISEASE (2016)
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Roser Busca et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The future of patient-derived tumor xenografts in cancer treatment
Daniela Sia et al.
PHARMACOGENOMICS (2015)
Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling
Hongxia Cui et al.
ONCOLOGY REPORTS (2015)
Relationship between EGFR Over-expression and Clinicopathologic Characteristics in Squamous Cell Carcinoma of the Esophagus: A Meta-analysis
Jun Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs et al.
LANCET (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer
Meilan Chen et al.
BMC CANCER (2013)
Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
Despina Siolas et al.
CANCER RESEARCH (2013)
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
Thomas Crosby et al.
LANCET ONCOLOGY (2013)
Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions
Alastair J. King et al.
PLOS ONE (2013)
ERK Pathway Inhibitors: How Low Should We Go?
Moriah H. Nissan et al.
CANCER DISCOVERY (2013)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
Regulation and function of the RSK family of protein kinases
Yves Romeo et al.
BIOCHEMICAL JOURNAL (2012)
Cancer statistics for Hispanics/Latinos, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Ethyl Gallate Induces Apoptosis of HL-60 Cells by Promoting the Expression of Caspases-8,-9,-3, Apoptosis-Inducing Factor and Endonuclease G
Woong-Hyun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition
Aidan G. Gilmartin et al.
CLINICAL CANCER RESEARCH (2011)
Free Radical Scavenging, Cytotoxic, and Hemolytic Activities of an Active Antioxidant Compound Ethyl Gallate from Leaves of Acacia Nilotica (L.) Wild. Ex. Delile Subsp Indica (Benth.) Brenan
T. Kalaivani et al.
JOURNAL OF FOOD SCIENCE (2011)
Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Alexander Link et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
RSK Is a Principal Effector of the RAS-ERK Pathway for Eliciting a Coordinate Promotile/Invasive Gene Program and Phenotype in Epithelial Cells
Ulrik Doehn et al.
MOLECULAR CELL (2009)
Cell fate decisions are specified by the dynamic ERK interactome
Alex von Kriegsheim et al.
NATURE CELL BIOLOGY (2009)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Diterpenoids from the roots of Euphorbia fischeriana
Yu-Bo Wang et al.
JOURNAL OF NATURAL PRODUCTS (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
分享论文
